Last updated: July 4, 2026

UnitedHealthcare Connecticut Weight Loss Treatment Coverage | Klarity Health

If you have UnitedHealthcare (UHC) insurance in Connecticut and are exploring online weight loss treatment, understanding what your plan may cover can help you access care with fewer surprises. UHC is one of Connecticut’s largest commercial insurers, offering individual and employer-sponsored plans through Access Health CT, fully-insured group plans, and self-funded employer plans — each with different coverage rules for weight loss medications, behavioral counseling, and telehealth services.

Check if your UnitedHealthcare plan may cover weight loss treatment in Connecticut →

Coverage varies by plan. Verify your benefits before booking. This page is for informational purposes only and does not constitute insurance or medical advice.

Does UnitedHealthcare Cover Weight Loss Treatment in Connecticut?

UHC plans in Connecticut may cover a range of weight loss services depending on your specific plan type and formulary. Covered services may include:

• Telehealth provider visits for weight management evaluation and monitoring
• Prescription weight loss medications (subject to formulary tier, prior authorization, and step therapy requirements)
• Behavioral health counseling when weight issues intersect with mental health conditions such as binge eating disorder or depression
• Lab work ordered in connection with weight management care

Coverage is plan-specific. Individual and small-group plans purchased through Access Health CT (the state’s ACA exchange) are required to cover certain preventive services, but prescription weight loss medications are not uniformly mandated as essential health benefits (EHB) under federal ACA rules. Self-funded employer plans — which fall under ERISA federal law — are not subject to Connecticut state insurance mandates and may have different benefit structures.

Connecticut Telehealth Parity and Mental Health Parity

Connecticut’s telehealth parity law requires fully-insured health plans to cover telehealth services on parity with in-person care when the service is clinically appropriate for remote delivery. Weight management consultations, prescription evaluations, and follow-up visits conducted via video with a licensed provider typically qualify under this parity framework for fully-insured UHC plans regulated by the Connecticut Insurance Department (CID) at 1-800-203-3447.

Under CGS § 38a-514b, fully-insured UHC plans in Connecticut must also cover mental health and substance use disorder services on parity with medical and surgical benefits. While weight loss is primarily a medical condition, when treatment addresses behavioral health comorbidities — such as binge eating disorder, depression linked to obesity, or anxiety related to body image — the mental health parity protections under CGS § 38a-514b may apply to those components of care.

ERISA note: Self-funded employer plans are governed by federal ERISA law and are not required to follow Connecticut’s state telehealth parity or mental health parity mandates under CGS § 38a-514b. If you are on a self-funded plan (common at larger employers), your benefits are determined entirely by your Summary Plan Description (SPD). Contact your HR department or plan administrator to verify your specific weight loss coverage.

UnitedHealthcare Weight Loss Medication Formulary (Connecticut)

UHC’s prescription drug formulary for Connecticut-regulated plans organizes medications into tiers that determine your copay or coinsurance. Weight loss medications often require prior authorization (PA) before coverage applies. The summary below reflects UHC’s typical national and Connecticut formulary structure — confirm your specific plan formulary through your UHC member portal or by calling the member services number on your insurance card.

GLP-1 Receptor Agonists (Weight Loss Indication)

Wegovy (semaglutide, weight loss indication): Tier 3–4 on most UHC commercial plans. Prior authorization is required. Coverage criteria typically include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, or dyslipidemia), plus documentation of a structured weight management program. Step therapy may apply — some UHC plans require a trial of lower-cost agents before Wegovy is approved.

Zepbound (tirzepatide, weight loss indication): Coverage is plan-specific. As a newer GLP-1/GIP dual agonist approved specifically for chronic weight management, Zepbound is increasingly appearing on UHC formularies at Tier 3–4 with PA required. BMI criteria similar to Wegovy typically apply. Verify availability through your plan’s drug look-up tool, as formulary placement for Zepbound varies more than for Wegovy.

Important distinction — Ozempic and Mounjaro: Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes management, not for weight loss alone. UHC typically covers these medications only when prescribed for their diabetes indication. If your provider prescribes Ozempic or Mounjaro solely for weight management and you do not have a documented type 2 diabetes diagnosis, coverage is generally not available under UHC’s standard formulary. Patients seeking GLP-1 coverage specifically for weight management should ask their provider about Wegovy (semaglutide, weight loss indication) or Zepbound (tirzepatide, weight loss indication) — the formulations with the FDA-approved weight management indication.

Saxenda (liraglutide): An older GLP-1 agonist approved for chronic weight management. Typically Tier 3 on most UHC plans; step therapy may require a trial of phentermine or other first-line agents before approval. PA is required. Saxenda is increasingly being superseded by Wegovy and Zepbound in clinical practice due to the newer agents’ greater efficacy data.

Non-GLP-1 Prescription Weight Loss Medications

Phentermine (generic): Tier 1–2 on most UHC plans; no prior authorization typically required. Phentermine is a Schedule IV controlled substance (DEA) with a 30-day supply quantity limit per dispense. It is the most accessible prescription weight loss option under most UHC formularies, but it is FDA-approved only for short-term use (typically up to 12 weeks). It is not appropriate for patients with cardiovascular disease, uncontrolled hypertension, or a history of substance use disorder.

Qsymia (phentermine + topiramate ER): Tier 3–4 on most UHC plans; step therapy and PA are typically required. Qsymia is a Schedule IV controlled substance, and 30-day supply quantity limits apply. Plans generally require documented failure of lifestyle modification and may require a prior trial of phentermine monotherapy before approving Qsymia.

Contrave (naltrexone/bupropion ER): Tier 3–4; step therapy and PA likely required. Non-controlled. Some UHC plans may require trial of lower-tier options before approving Contrave. Coverage is not universal across all UHC plan designs.

Orlistat (generic): Typically low-tier (Tier 1–2) or available over the counter. Limited clinical use in current practice due to gastrointestinal side effects and modest long-term efficacy compared to GLP-1 agents.

Prior Authorization Requirements for Weight Loss Medications

Most UHC weight loss prescriptions — particularly GLP-1 agonists — require prior authorization before the pharmacy will dispense the medication. Your Klarity Health provider will submit a PA request to UHC with clinical documentation, typically including:

• Current BMI measurement and weight history
• Relevant comorbidities (hypertension, type 2 diabetes, dyslipidemia, sleep apnea)
• Documentation of prior weight management efforts (diet, exercise, previous medications)
• Medical necessity statement

Standard PA review typically takes 2–5 business days. Expedited review (72 hours) is available when a standard timeline would seriously jeopardize your health or ability to receive ongoing care. If UHC denies the PA request, you have the right to a formal internal appeal and, if the internal appeal is upheld, an external independent review through the Connecticut Insurance Department.

Check if your UnitedHealthcare plan may cover weight loss treatment in Connecticut →

UnitedHealthcare Plan Types in Connecticut

Your coverage structure depends on which UHC plan type you have:

• PPO / EPO: No referral required to see a specialist or access telehealth weight loss services. You can book directly with a Klarity Health provider without a PCP referral.
• HMO: A primary care physician (PCP) referral is required before specialist visits. If you have a UHC HMO plan in Connecticut, confirm whether your PCP can issue a referral for a telehealth weight management provider.
• Medicare Advantage: UHC is a major Medicare Advantage carrier in Connecticut. Medicare Advantage plans have their own formularies governed by CMS rules. Medicare Part D has historically excluded drugs prescribed solely for weight loss, though coverage for GLP-1 weight loss agents is evolving under recent CMS guidance. Verify your specific MA plan formulary separately from your commercial plan information.
• Access Health CT (ACA exchange) plans: Plans purchased through Access Health CT are fully-insured and subject to Connecticut state insurance law, including telehealth parity. ACA-compliant plans cover preventive services and obesity screening and counseling, but prescription weight loss drugs are not a required EHB category at the federal level. Coverage varies by plan metal tier and the insurer’s own formulary decisions.

How Klarity Health Works with UnitedHealthcare

Klarity Health connects patients with 2,000+ licensed providers across the United States, including physicians and nurse practitioners who specialize in weight management and metabolic health. During your telehealth visit, your provider evaluates your medical history, current weight, and health goals, and discusses whether prescription weight loss medications may be appropriate for your situation.

If a prescription is indicated and you have UHC insurance, your Klarity Health provider can assist with prior authorization documentation and submit the necessary clinical information to support your PA request. Because GLP-1 PA approvals depend on documented medical necessity, having a licensed provider prepare and submit the PA request typically results in a more efficient review process.

Klarity Health operates entirely via telehealth — visits are conducted by video from your home. Connecticut’s telehealth parity law means your UHC fully-insured plan should cover these visits at the same cost-sharing level as an in-person appointment when the service is clinically appropriate for telehealth delivery.

Appealing a Weight Loss Coverage Denial

If UHC denies a PA request for a weight loss medication, you have several appeal options under Connecticut insurance law:

1. Internal appeal: Submit a written appeal to UHC within 180 days of the denial. Include additional clinical documentation from your provider — updated BMI records, comorbidity documentation, and peer-reviewed evidence supporting the medication.
2. External independent review: If UHC upholds the denial on internal appeal, you can request an external review by an independent organization through the Connecticut Insurance Department.
3. CID complaint: If you believe UHC is not following Connecticut insurance law or is engaging in unfair claims practices, file a complaint with the Connecticut Insurance Department at 1-800-203-3447.

Under CGS § 38a-514b and Connecticut’s external review statute, fully-insured plan members have enforceable rights to these appeal processes. ERISA self-funded plan members are subject to federal claims and appeals regulations under ERISA Section 503 rather than state law processes.

Frequently Asked Questions

Does UnitedHealthcare cover Wegovy in Connecticut?

UHC may cover Wegovy (semaglutide, weight loss indication) on fully-insured Connecticut plans, typically at Tier 3–4 with prior authorization required. Coverage criteria generally include a BMI of 30 or higher, or 27 or higher with a documented comorbidity. Coverage is not guaranteed and varies by specific plan. Verify your benefits through your UHC member portal or by calling the number on your insurance card before starting treatment.

Does UnitedHealthcare cover Ozempic for weight loss in Connecticut?

Ozempic is FDA-approved for type 2 diabetes, not for weight loss alone. UHC typically covers Ozempic only when prescribed for a documented type 2 diabetes diagnosis. If you do not have type 2 diabetes and are seeking GLP-1 coverage for weight management, ask your provider about Wegovy or Zepbound, which carry the FDA-approved weight management indication and are more likely to be covered under UHC’s weight loss formulary.

Does UnitedHealthcare cover Zepbound in Connecticut?

Zepbound (tirzepatide, weight loss indication) may appear on UHC formularies in Connecticut at Tier 3–4 with PA requirements. Coverage is plan-specific and evolving as Zepbound is a newer agent. Check your plan’s formulary tool directly, as Zepbound coverage availability varies more than Wegovy at this time.

Does UHC cover phentermine in Connecticut?

Generic phentermine is typically covered at Tier 1–2 on UHC plans with no prior authorization required, making it the most easily accessible prescription weight loss medication under most UHC formularies in Connecticut. It is a Schedule IV controlled substance with a 30-day supply limit per fill and is FDA-approved only for short-term use.

Can I access weight loss treatment through telehealth on UHC in Connecticut?

Yes. For fully-insured UHC plans in Connecticut, telehealth weight loss visits are typically covered on parity with in-person care under Connecticut’s telehealth parity law. Self-funded employer plans are not subject to this state mandate, so verify with your employer’s HR or plan administrator. Klarity Health provides telehealth weight loss treatment visits compatible with most fully-insured UHC plans.

What if my UHC prior authorization for a weight loss medication is denied?

You can file an internal appeal with UHC within 180 days of the denial. If the internal appeal is denied, you may request an external independent review. You can also contact the Connecticut Insurance Department at 1-800-203-3447 for guidance or to file a complaint if you believe your fully-insured UHC plan is not complying with Connecticut insurance law.

Check if your UnitedHealthcare plan may cover weight loss treatment in Connecticut →
See if you may qualify for online weight loss treatment at Klarity Health →